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ABSTRACT 
Objective: To estimate incidence and lifetime risk of diagnosed symptomatic knee OA 
and age of diagnosis of knee OA based on self-reports in the US population. 
Methods: We estimated incidence of diagnosed symptomatic knee OA in the US by 
combining data on age-, sex-, and obesity-specific prevalence from the 2007-2008 
National Health Interview Survey (NHIS) with disease duration estimates derived from 
the Osteoarthritis Policy (OAPol) Model, a validated computer simulation model of knee 
OA. We used the OAPol Model to estimate the mean and median age of diagnosis and 
lifetime risk.  
Results: The estimated incidence of diagnosed symptomatic knee OA was highest 
among adults aged 55 to 64, ranging from 0.37% per year for non-obese males to 
1.02% per year for obese females. The estimated median age of knee OA diagnosis 
was 55 years. The estimated lifetime risk was 13.8%, ranging from 9.6% for non-obese 
males to 23.9% in obese females. About 9% of the US population is diagnosed with 
symptomatic knee OA by age 60. 
Conclusion: The diagnosis of symptomatic knee OA occurs relatively early in life 
suggesting that prevention programs should be offered relatively early in the life course. 
Further research is needed to understand the future burden of healthcare utilization 
resulting from earlier diagnosis of knee OA. 
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SIGNIFICANCE AND INNOVATIONS 
• We provide estimates of the incidence of diagnosed symptomatic knee OA in the 
US using population-based national data from 2007-2008. 
• The estimated mean and median age of diagnosis of symptomatic knee OA was 
55 years. 
• With half of cases of symptomatic knee OA diagnosed by age 55, the burden of 
future healthcare utilization for knee OA may be high. 
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INTRODUCTION 
Knee osteoarthritis (OA) is a painful, disabling condition that affects an estimated 9.3 
million US adults.1 Because no disease-modifying treatments are available, treatments 
for symptomatic knee OA focus on symptom relief and functional restoration, including 
physical therapy, medications, joint injections, and total knee replacement.2-5  
For decades, knee OA had been viewed as a disease mostly affecting older persons. 
However, recent evidence documents increased  incidence of two key risk factors for 
knee OA – traumatic knee injury6 and obesity,7, 8 particularly in younger persons.9, 10 
Evolving data point to high prevalence of posttraumatic knee OA in younger persons.11-
13 This trend and the increasing prevalence of obesity among children are likely to lead 
to increased rates of osteoarthritis in young adults.14  
Most population-based data on knee OA prevalence and incidence refer to studies 
conducted in the mid-1990s.15-17 In fact, the two most recent studies reporting incidence 
of symptomatic knee OA in the US were published 17 years ago in 1995.15, 16 
Furthermore, although obesity is a known risk factor, no studies have reported age- and 
sex-specific knee OA incidence separately for obese and non-obese persons. 
Determining the age of diagnosis of symptomatic knee OA is critical to understanding 
the trajectory of decrements in quality of life and utilization of health services. 
We sought to use national self-reported data to derive current age-, sex-, and obesity-
stratified estimates of the incidence of diagnosed symptomatic knee OA, to estimate the 
mean and median age of diagnosis, and to estimate the lifetime risk of diagnosis among 
25 year olds representative of the US population.  
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MATERIALS AND METHODS 
Analytic overview 
The incidence of diagnosed symptomatic knee OA was derived as a ratio of disease 
prevalence odds to disease duration (see Technical Appendix for a more detailed 
explanation of incidence calculations).18 We used self-reported data from the 2007-
2008 NHIS to estimate the prevalence of diagnosed symptomatic knee OA.19 Disease 
duration was derived using the Osteoarthritis Policy (OAPol) Model, a published and 
validated computer simulation model of knee OA natural history and management.20, 21 
Incidence was estimated within 10-year age groups and was further stratified by sex 
and obesity status.  
We then used the OAPol Model and our newly derived incidence estimates to determine 
mean and median ages of diagnosis of symptomatic knee OA in the US. To model 
disease duration, cohorts were initialized with knee OA, and the output of interest 
was life expectancy. To model age of diagnosis, cohorts were initialized without 
knee OA, and the output of interest was the development of OA, or cumulative 
incidence of OA. 
 
OAPol Model 
The OAPol Model is a validated, state transition Monte Carlo computer simulation 
model of the natural history of knee OA.20, 21 “State transition” implies that the natural 
history and clinical management of knee OA are characterized as a series of annual 
transitions between health states. The health states are characterized by age, sex, 
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obesity, comorbidities, and knee OA disease severity among those who develop the 
condition. The model uses a set of transition probabilities to determine each individual’s 
sequence of annual transitions among different health states that include being 
diagnosed with symptomatic knee OA. Every subject without knee OA is considered to 
be at risk for knee OA. The risk is governed by age, sex, and obesity (defined by BMI ≥ 
30 kg/m2).  
 In addition to capturing the risk of knee OA, the model tracks chronic comorbidities that 
increase mortality either directly (coronary heart disease, cancers, and obesity), and/or 
by increasing the risk of other chronic diseases (diabetes mellitus and obesity).Each 
simulated person is followed by the model until death. Death can occur from any health 
state. Underlying mortality for all individuals was derived from CDC life tables with 
disease-specific mortality removed.19, 22-24 All-cause mortality rates were obtained from 
CDC life tables. The additional mortality attributable to chronic comorbidities (coronary 
heart disease, cancer, and obesity) were then removed from the mortality in Life Tables 
to estimate the mortality rates for healthy individuals, for all age and sex strata.  These 
attributable mortality rates were then used for those with corresponding 
comorbidities.  Further details of the OAPol Model structure have been published 
elsewhere,20, 21 and can also be found in Technical Appendix. 
 
Estimating current prevalence of diagnosed symptomatic knee OA  
We used self-reported data from the 2007-2008 NHIS to estimate the prevalence of 
diagnosed symptomatic knee OA.19 The NHIS is a cross-sectional survey that is 
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representative of the civilian non-institutionalized population residing in the United 
States. The adult sample, which was the basis of our analysis, was comprised of 
persons 18 years of age or older. For the purposes of our analysis we included persons 
that were 25 years of age or older. 
Survey participants were considered to have prevalent knee OA if they: 1) answered 
“Yes” to the questions “Have you ever been told by a doctor or other health 
professional that you have some form of arthritis, rheumatoid arthritis, gout, 
lupus, or fibromyalgia?” and “During the past 30 days, have you had any 
symptoms of pain, aching, or stiffness in or around a joint?”; 2) specified the 
knee as an affected joint; and 3) did not report having rheumatoid arthritis, lupus, 
fibromyalgia, or gout. We used a logistic regression model that accounted for the 
complex survey design to derive age-, sex-, and obesity-stratified population-based 
prevalence estimates of the prevalence of self-reported diagnosed symptomatic knee 
OA. The regression model included age, up to the fourth degree and the interaction 
between obesity and sex and was built using SAS 9.2 (SAS 9.2 (SAS Institute, Cary, 
NC).  
Similar algorithms for classifying survey respondents as having symptomatic knee OA 
have shown specificity greater than 90%,25, 26 which indicate that these algorithms 
perform well in terms of classifying patients without symptomatic knee OA. Since self-
reported data may likely overstate the true prevalence of diagnosed symptomatic knee 
OA, we used published data on the positive predictive value of self-reported diagnosed 
symptomatic knee OA to reduce the prevalence estimates and the corresponding 95% 
CIs. Specifically, we assumed that the PPV was lower for those younger than age 60 
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(PPV=66.0%)27 compared with those ages 60 and older (PPV=80.7%).26  For instance, 
for a non-obese male aged 44 with self-reported prevalence of symptomatic knee 
OA at 0.0374, the PPV-adjusted prevalence was estimated at 0.0247, or 66.0% of 
the self-reported prevalence. Similarly, for an obese female aged 64, the predicted 
prevalence would be 80.7% of the self-reported prevalence at 0.2864, or 0.2311.  
These reduced prevalence data and 95% CIs were used as benchmarks for the 
calibration of OA incidence. 
 
Estimating incidence of diagnosed symptomatic knee OA 
We estimated the incidence rates of diagnosed symptomatic knee OA as a ratio of the 
NHIS 2007-2008, PPV-adjusted prevalence estimates to disease duration.18 Because 
there is no cure for knee OA, to derive disease duration we used the OAPol Model to 
simulate life expectancy within each decade of age, further stratified by sex and obesity 
(for details see Technical Appendix, 2A). Incidence rates within 10-year age groups 
between 25 and 85 years were then estimated by dividing PPV-adjusted prevalence 
rates by model-derived disease durations.   
Disease duration was calculated as an average 10-year survival of persons 
affected by OA, diagnosed within each year of the decade, assuming constant 
rate of diagnosis in every year of a given decade. The analysis was conducted for 
the cohort with race/sex and obesity distribution similar to the distribution of 
persons affected by knee OA in the US as well as separately for each 
age/sex/race and obesity cohorts with knee OA. 
11 
The calculated incidence estimates were calibrated to generate model-based 
prevalences that fell within the 95% CIs for the prevalence estimates derived from NHIS 
2007-2008 (For details see Technical Appendix). 95% CI for incidence were calculated 
empirically based on model results, using normal approximation of Poisson distribution, 
with empirical incidence rates calculated as the number of new cases of diagnosed OA 
from the model output, divided it by the time ‘at risk’, defined as sum of  years alive 
without knee OA within each decade. 
 
 
Estimating lifetime risk of diagnosed symptomatic knee OA and average age at 
diagnosis 
Using the OAPol Model and our calculated incidence rates, we estimated lifetime risk 
of diagnosed symptomatic knee OA from age 25, defined as the cumulative probability 
of being diagnosed with symptomatic knee OA over the lifetime for US adults in each of 
the five cohorts described below. The lifetime risk was calculated by dividing the 
cumulative number of incident cases of diagnosed symptomatic knee OA within each 
cohort predicted by the OAPol Model by the size of the initial population at risk for the 
disease reported by US Census data. We used the OAPol Model to estimate the 
mean and median age of symptomatic knee OA diagnosis using the derived incidence 
rates. Mean age was obtained by constructing a distribution by age of all incident cases 
of diagnosed symptomatic knee OA based on the OAPol Model and calculating a 
mean of this distribution.  Median age represented the age at which 50% of those 
ultimately diagnosed with symptomatic knee OA had been diagnosed (i.e. the 50% mark 
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of the cumulative distribution function of incident cases). Mean age is reported to one 
tenth of a year; median age is reported as an integer. 
 
Populations under consideration 
Using the OAPol Model, we simulated five cohorts that were followed from age 25 until 
death: 1) non-obese females; 2) obese females; 3) non-obese males; 4) obese males; 
and 5) the general US population. For non-obese cohorts, mean BMI at age 25 was 
25.0 kg/m2 with a standard deviation (SD) of 0.5 kg/m2. For obese cohorts, mean BMI 
was 34.5 kg/m2 with a SD of 1.5 kg/m2. For the general US population, BMI 
distributions, stratified by sex and race/ethnicity, were derived from the 2005-2008 
National Health and Nutrition Examination Survey (NHANES) and ranged from a mean 
BMI of 26.7 kg/m2 with a SD of 6.1 kg/m2 for white, non-Hispanic males at age 25 
to a mean BMI of 30.2 kg/m2 with a SD of 8.8 kg/m2 for black, non-Hispanic 
females at age 25 (Table 1).28, 29 The distributions of sex and race/ethnicity within each 
cohort were derived from 2009 US Census data.30 Prevalence rates of comorbid 
conditions, including cancer, coronary heart disease, and diabetes mellitus, were 
stratified by age, sex, and race/ethnicity and were derived from the 2005-2008 NHANES 
(Table 1).28, 29 Incidence rates for comorbidities were calculated as the ratio of 
prevalence odds to disease duration. We assumed that chronic comorbid 
conditions cannot be cured in the model, so life expectancies of persons with 
these comorbidities were used as a measure of disease duration. Dividing 
prevalence odds derived from NHANES 2005-2008 data by estimated disease 
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duration led to estimates of the comorbid incidence rates used in the model, 
stratified by age, sex, and race/ethnicity (Table 1).  
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RESULTS 
Estimated prevalence of diagnosed symptomatic knee OA 
Age-, sex-, and obesity-stratified estimates of the prevalence of diagnosed symptomatic 
knee OA are presented in Table 2. For non-obese males, the estimated prevalence 
ranged from 0.74% among those aged 25 to 34 to 12.94% in those older than 85 years. 
For non-obese females, estimated prevalence ranged from 0.88% for the youngest age 
group (25 to 34 years) to 14.97% among those older than 85 years of age. For obese 
males, the estimated prevalence ranged from 1.54% in the youngest group to 23.54% in 
the oldest group. Obese females had the highest estimated prevalence ranging from 
2.41% for the youngest group to 32.45% in the oldest age group. 
 
Estimated incidence of diagnosed symptomatic knee OA 
For non-obese males, estimated disease duration within each decade ranged 
from 5.48 years for the youngest age group to 3.39 years for the 85+ age group. 
For obese males, estimated disease duration ranged from 5.47 years to 3.39 years 
in for the 25-34 year olds and 85+ year olds, respectively. For non-obese and 
obese females, estimated disease duration ranged from 5.49 years among those 
aged 35-34 to 3.89 years among those over 85 years old. 
Estimated annual incidences of diagnosed symptomatic knee OA, stratified by age, sex, 
and obesity, are presented in Table 2. Estimated incidence ranged from 0.12% per year 
in the youngest non-obese males to 1.02% per year in obese females aged 55 to 64 
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years. For all sex and obesity status combinations, incidence peaked at ages 55 to 64 
and was lowest among those older than age 85. For non-obese males, incidence 
ranged from 0.04% to 0.37% per year. For non-obese females, incidence ranged from 
0.06% to 0.43% per year. Among obese males, incidence ranged from 0.05% per year 
to 0.64% per year. For obese females, incidence ranged from 0.10% to 1.02% per year. 
Results of the internal validation analysis using our current incidence estimates are 
presented in Figure 1. Within each 10-year age group, the model-based prevalence 
estimates fell within the 95% CI of the NHIS data for each cohort, defined by sex and 
obesity status.  
 
Estimated age of diagnosis of symptomatic knee OA 
Using current demographic, obesity, and comorbidity profiles representative of the 
general population in the US, the estimated mean age of symptomatic knee OA 
diagnosis was 53.5 (SD = 14.4). The estimated median age of diagnosis of symptomatic 
knee OA was 55 years (Figure 2). 
 
Lifetime risk of diagnosed symptomatic knee OA 
The lifetime risk of diagnosed symptomatic knee OA from age 25 in the US population 
was estimated at 13.8%, with a 9.3% risk of having diagnosed symptomatic knee OA by 
age 60 (Figure 3). In obese persons, lifetime risk of diagnosed knee OA was estimated 
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at 19.7% compared to 10.9% for non-obese persons. In females, the lifetime risk was 
estimated at 16.3% compared to 11.4% in males. In sex- and obesity-stratified cohorts, 
we estimated the lifetime risk to be highest in obese females at 23.9% and lowest in 
non-obese males at 9.6%. 
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DISCUSSION 
We used the OAPol Model, a state transition Monte Carlo computer simulation model, 
combined with national data from the 2007-2008 NHIS on the prevalence of diagnosed 
symptomatic knee OA, to estimate the annual incidence of diagnosed symptomatic 
knee OA in the US . We estimated that incidence peaked during ages 55 to 64; was 
higher among obese persons than non-obese persons; and, adjusting for obesity, was 
higher among females than males. The estimated median age of knee OA diagnosis 
was 55 years of age. Our incidence estimates were derived with an approach that 
relates incidence, prevalence odds and disease duration (prevalence 
odds/disease duration=incidence rate). Prevalence was obtained from a national 
population-based cross-sectional study. To ensure a ‘stable population’ we 
considered prevalence to be stable within 10-year age intervals. This method is 
widely used when longitudinal data are not available.  
This study adds important insights to research on OA incidence. Until now a report from 
the early 1990s provided the most recently published estimates of incidence of 
diagnosed symptomatic knee OA.15-17 Our contemporary estimates are consistent with 
prior literature in showing higher incidence of diagnosed knee OA among females16 and 
among obese individuals.8, 31, 32  
Our estimates also provide insight into the differential impact of obesity on diagnosed 
OA incidence across age and sex strata. A recent study from the Johnston County 
Osteoarthritis Project in North Carolina found that lifetime risk of symptomatic knee OA 
from age 45 was nearly 45%,33 considerably greater than our estimate of 16%. Several 
18 
differences in study design and population may explain this difference. First, the 
Johnston County study utilized radiographs to define symptomatic knee OA. 
Unpublished data from the Johnston County Osteoarthritis Project indicate that only 
about 2/3 of those identified as having symptomatic knee OA reported being diagnosed 
with OA by a health professional. Second, the current study projected lifetime risk from 
an earlier age (25 years), while the Johnston County study estimated lifetime risk from 
age 45.33 Third, differences between the study populations in Johnston County and the 
NHIS may also account for some of the differences in estimated lifetime risk. Indeed, 
when we ran a cohort through the model using the sex, race, and body mass index 
distributions, as well as the incidence, prevalence, and progression of symptomatic knee 
OA, representative of the Johnston County population, the lifetime risk for developing 
knee OA increased from 16% to 38% -- similar to the 45% risk reported in the Johnston 
County study. The remaining differences may reflect the fact that while the Johnston 
County Study had good follow up, not everybody returned for the follow up assessment. 
As in many cohorts, those participants who developed OA were more likely to return to 
for follow up assessments, increasing estimates of OA risk. 
The estimated rates of diagnosed knee OA incidence differ somewhat from prior 
studies published 10-20 years ago. The study by Oliveria et al, published in 1995 
based on the data from a Fallon health plan, used medical records to estimate 
annual incidence of diagnosed knee OA. Authors found that incidence of 
diagnosed symptomatic knee OA increases with increasing age until age 80).16 
Earlier peak of incidence estimated in our study is consistent with the trend of 
earlier diagnosis and earlier use of TKR. 
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 Our estimates suggest that persons aged 55 to 64 today are at highest risk for a new 
diagnosis of symptomatic knee OA, with incidence of diagnosed disease tapering off in 
older ages. If these differences are indicative of secular trends, they may reflect 
increased likelihood of diagnosis earlier in life rather than earlier onset of biological 
disease. An increase in the rate of diagnosed cases could result from increased patient 
awareness of knee OA, as well as a heightened inclination to diagnose knee OA on the 
part of physicians. Because rigorous comparisons between our findings and the study 
by Oliveria and colleagues are limited by methodological differences and heterogeneity 
in the study populations, further research is needed to understand secular trends in the 
diagnosis and incidence of symptomatic knee OA. 
Our findings have important implications for disease prevention and health care 
utilization. The early median age of diagnosis of symptomatic knee OA (55 years) 
suggests that public health officials should introduce prevention strategies relatively 
early in the life course. Policymakers should implement prevention strategies aimed at 
reducing obesity and the risk of knee injury, two major risk factors for knee OA. 
Furthermore, the early age of diagnosis of symptomatic knee OA may yield high levels 
of lifetime health care utilization and costs. In the last decade, the mean age of total 
knee replacement (TKR) has decreased from 69 to 66 years and utilization of TKR has 
tripled among US adults aged 45 to 64.34 Whether health outcomes improve as a result 
of early diagnosis of symptomatic knee OA offers a rich area for future research. 
The results from this study should be viewed within the context of certain assumptions 
and limitations in our approach. First, the definition of OA poses challenges.35 The 
incidence estimates reported here depend on the method used to define diagnosed 
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symptomatic knee OA. To derive population-based national data we relied on a national 
survey (NHIS 2007-2008), which relies on self-reported data. Diagnosed symptomatic 
knee OA was defined based on self-reported responses to several questions 
asked in the survey. Certain questions pertain more to recent knee pain than to 
chronic knee pain, which would serve as a better indicator of knee OA 
prevalence. However, similar algorithms to the one we used have specificity greater 
than 90%.25, 26 To account for possible misclassification in the self-reported prevalence 
of diagnosed symptomatic knee OA from the 2007-2008 NHIS survey data, we applied 
positive predictive values from published studies to the younger and older age 
groups.25-27 We could not identify any published data on predictive negative values 
in relationship to under-reporting of diagnosed symptomatic knee OA, therefore 
our estimates of lifetime risk of diagnosed knee OA are conservative. 
Furthermore, the sample size and national scope of the NHIS offer advantages over 
smaller, geographically-limited observational studies. Second, we assumed constant 
annual incidence of symptomatic knee OA within 10-year age strata. While a more 
precise method might have captured a smoother age distribution, incidence of the 
disease is unlikely to differ enough across any 10-year age group to have a meaningful 
effect on our estimates.  
Our estimates suggest that diagnosis of symptomatic knee OA occurs early in the life 
course (median age 55 years), with incidence peaking between ages 55 and 64. Early 
diagnosis of symptomatic knee OA may yield future increases in health care utilization 
and medical costs associated with knee OA. Physicians and policymakers can use our 
findings to direct resources toward preventing risk factors for knee OA. Policymakers 
21 
and planners can also use our estimates to prepare for the potential future burden on 
the US health care system resulting from the early age of diagnosis of symptomatic 
knee OA. 
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Table 1. Baseline Demographic and Clinical Characteristics of US Adults Aged 25 
Years 
Initial age 25.0     Source 
Race/ethnicity 
(all cohorts) Male Female   2009 US Census 
Population 
Estimates30 
White, non-Hispanic (%) 63.7 65.0   
Hispanic (%) 20.9 18.8   
Black, non-Hispanic (%) 15.4 16.1   
  Mean BMI (standard deviation) (kg/m2)   
Cohort Male Female     
Non-obese 25.0 (0.5) 25.0 (0.5) Maximum: 29.9¯    
Obese 34.5 (1.5) 34.5 (1.5) Minimum: 30.0   
Overall US Population       
NHANES 
2005-200828, 29 
    White, non-Hispanic 26.7 (6.1) 26.8 (7.7)   
    Hispanic 27.6 (6.0) 28.0 (6.7)   
    Black, non-Hispanic 27.7 (6.2) 30.2 (8.8)   
Comorbid condition Prevalencea Incidencea 
Relative risk of 
mortalitya,b,c 
NHANES 
2005-200828, 29 
Cancer 0.0% - 5.7% 0.0% - 6.4% 1.0 - 30.0 
Coronary heart disease 0.0% - 0.3% 0.0% - 4.4% 1.0 - 36.6 
Diabetes mellitus 1.5% - 7.0% 0.0% - 5.1% 1.0d 
 
a Prevalence of comorbid conditions is stratified by sex, race/ethnicity, and obesity 
status. Incidence and relative risks of mortality for comorbid conditions are stratified by 
age, sex, race/ethnicity, and obesity status. The ranges of values across these 
stratifications are presented in this table. 
28 
b For individuals with more than one of the comorbid conditions listed here, the model 
assigns only the maximum of the relative risks of mortality associated with those 
separate conditions (i.e. relative risks are not cumulative; an individual with a 1.5 
relative risk of mortality due to coronary heart disease and a 3.5 relative risk of mortality 
due to cancer will experience a relative risk of morality of 3.5) . 
c The relative risk of mortality due to obesity ranged from 1.0 to 2.5. 
d While diabetes mellitus does not directly increase the risk of mortality in the model, 
individuals with diabetes mellitus are at increased risk for developing coronary heart 
disease, which can increase the risk of mortality. 
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Table 2. Estimated Prevalence and Incidence of Diagnosed Symptomatic Knee OA 
by Age, Sex, and Obesity Status 
Obesity 
status Sex Age 
Estimated prevalence (%) 
(using NHIS 2007-08 data) 
(95% CI) 
Estimated incidence  
(annual, %) 
Non-obese Male 25-34 0.74 (0.61, 0.89) 0.12 (0.12, 0.12) 
    35-44 1.74 (1.51, 2.00) 0.13 (0.12, 0.13) 
    45-54 3.61 (3.21, 4.06) 0.22 (0.22, 0.22) 
    55-64 6.70 (6.09, 7.37) 0.37 (0.37, 0.38) 
    65-74 9.83 (9.01, 10.71) 0.20 (0.19, 0.20) 
    75-84 11.64 (10.51, 12.88) 0.13 (0.12, 0.13) 
    85+ 12.94 (10.86, 15.34) 0.04 (0.04, 0.04) 
  Female 25-34 0.88 (0.73, 1.05) 0.14 (0.14, 0.14) 
    35-44 2.06 (1.83, 2.31) 0.15 (0.14, 0.15) 
    45-54 4.26 (3.90, 4.64) 0.27 (0.27, 0.27) 
    55-64 7.85 (7.22, 8.52) 0.43 (0.43, 0.43) 
    65-74 11.44 (10.48, 12.47) 0.27 (0.27, 0.27) 
    75-84 13.50 (12.44, 14.65) 0.16 (0.16, 0.16) 
    85+ 14.97 (13.04, 17.12) 0.06 (0.06, 0.06) 
30 
Obese Male 25-34 1.54 (1.26, 1.87) 0.25 (0.24, 0.25) 
    35-44 3.58 (3.12, 4.11) 0.24 (0.24, 0.24) 
    45-54 7.25 (6.49, 8.09) 0.44 (0.43, 0.44) 
    55-64 13.00 (11.76, 14.33) 0.64 (0.64, 0.65) 
    65-74 18.48 (16.71, 20.39) 0.32 (0.32, 0.33) 
    75-84 21.48 (19.33, 23.78) 0.17 (0.17, 0.18) 
    85+ 23.54 (20.24, 27.19) 0.05 (0.05, 0.05) 
  Female 25-34 2.41 (2.02, 2.88) 0.37 (0.37, 0.38) 
    35-44 5.53 (4.93, 6.21) 0.40 (0.39, 0.40) 
    45-54 10.93 (10.01, 11.92) 0.57 (0.57, 0.58) 
    55-64 18.94 (17.52, 20.44) 1.02 (1.01, 1.02) 
    65-74 26.20 (24.25, 28.23) 0.41 (0.40, 0.41) 
    75-84 29.94 (27.73, 32.23) 0.28 (0.27, 0.28) 
    85+ 32.45 (28.79, 36.31) 0.10 (0.10, 0.10) 
 
 
 
 
31 
FIGURE LEGEND 
Figure 1. Estimated Prevalence of Diagnosed Symptomatic Knee OA by Age in 
the US (Internal Validation of OAPol Model Estimates Using NHIS 2007-2008 Data) 
Dashed curves represent prevalence among non-obese persons and solid curves 
represent prevalence among obese persons. Female prevalence is in black; male 
prevalence is in gray. Prevalence from NHIS is depicted by squares for obese and 
diamonds for non-obese persons and accompanied by 95% confidence intervals. 
Figure 2. Estimated Age of Diagnosis among Persons with Symptomatic Knee OA 
The black curve is cumulative incidence using current incidence estimates. The vertical 
dashed line denotes the median age of diagnosis (i.e. the age by which 50% of cases 
have been diagnosed). 
Figure 3. Estimated Cumulative Incidence of Diagnosed Symptomatic Knee OA 
from Age 25 in the US Population, Stratified by Sex and Obesity Status 
The patterned dark gray curve represents the overall cumulative incidence of diagnosed 
symptomatic knee OA from age 25. Dashed curves represent cumulative incidence 
among non-obese persons; solid curves represent cumulative incidence among obese 
persons. Female cumulative incidence is in black; male cumulative incidence is in light 
gray. The cumulative incidence by end of life represents the lifetime risk for each cohort, 
as denoted in the right margin. The point of intersection of the thin black horizontal and 
vertical lines emphasizes the cumulative incidence for the general US population by age 
60. 
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Figure 1. Estimated Prevalence of Diagnosed Symptomatic Knee OA by Age in the US (Internal Validation of 
OAPol Model Estimates Using NHIS 2007-2008 Data) 
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Figure 2. Estimated Age of Diagnosis among Persons with Symptomatic Knee OA 
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Figure 3. Estimated Cumulative Incidence of Diagnosed Symptomatic Knee OA from Age 25 in the US Population, 
Stratified by Sex and Obesity Status 
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